mark w lowdell
Royal Free London NHS Foundation Trust
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
Community reviewers
Type at least 3 characters
Shape the future of research in your field
Join the board
Associate Editors
pedro lowenstein
University of Michigan
Ann Arbor, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
bin lu
University of South China
Hengyang, China
Associate Editor
Cancer Genetics
cheng lu
Guangdong Provincial People's Hospital
Guangzhou, China
Associate Editor
Cancer Imaging and Image-directed Interventions
chunwan lu
Tianjin University
Tianjin, China
Associate Editor
Cancer Immunity and Immunotherapy
huili lu
School of Pharmacy, Shanghai Jiao Tong University
Shanghai, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
jianrong lu
University of Florida
Gainesville, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
le lu
Alibaba DAMO Academy USA
Bethesda, United States
Associate Editor
Cancer Imaging and Image-directed Interventions
lijun lu
Southern Medical University
Guangzhou, China
Associate Editor
Cancer Imaging and Image-directed Interventions
ming-de lu
Sun Yat-sen University
Guangzhou, China
Associate Editor
Cancer Imaging and Image-directed Interventions
tzu pin lu
Department of Public Health, College of Public Health, National Taiwan University
Taipei, Taiwan
Associate Editor
Cancer Genetics
yao lu
Sun Yat-sen University
Guangzhou, China
Associate Editor
Breast Cancer
yong-chen lu
University of Arkansas for Medical Sciences
Little Rock, United States
Associate Editor
Cancer Immunity and Immunotherapy
yu jen lu
Chang Gung Memorial Hospital
Taipei, Taiwan
Associate Editor
Pharmacology of Anti-Cancer Drugs
zipeng lu
First Affiliated Hospital, Nanjing Medical University
Nanjing, China
Associate Editor
Surgical Oncology
alessandro lucidi
Asl Lanciano Vasto Chieti
Chieti, Italy
Associate Editor
Gynecological Oncology